GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.37598 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.98036 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TOP1, TYR, XDH |
6.97953 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, HMGCR, MIF, PIM1, PPARA, TYR, XDH |
6.83754 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, HMGCR, HSD17B1, HSD17B2, MET, MIF, PPARA |
6.65196 |
[BP] GO:0042221 |
response to chemical
|
ABCG2, AKR1B1, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC, TOP1, TYR |
6.47187 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.43289 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, HMGCR, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, XDH |
6.43289 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, HMGCR, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, XDH |
6.43289 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SRC, TYR |
6.43289 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, SRC |
6.43289 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, SRC |
6.01764 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MMP2, PPARA, RORC, SRC, TYR |
5.93884 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SRC, TOP1, TYR, XDH |
5.79907 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CSNK2A1, CYP1B1, FABP3, FLT3, HMGCR, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, SRC, XDH |
5.73944 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, SRC, XDH |
5.73747 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCG2, ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, KDR, MET, MIF, PPARA, SRC, XDH |
5.65877 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, F10, FABP3, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
5.45157 |
[BP] GO:0050896 |
response to stimulus
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SRC, TOP1, TYR |
5.45157 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, SRC, XDH |
5.45157 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2 |
5.33259 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, SRC |
5.29162 |
[BP] GO:0033993 |
response to lipid
|
AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, RORC, SRC, TYR |
5.2273 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC |
5.2273 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, F10, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
4.92807 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, HMGCR, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, SRC, XDH |
4.7457 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, F10, FABP4, HMGCR, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TOP1, TYR |
4.7457 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, F10, FLT3, HMGCR, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, XDH |
4.72339 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AXL, BCL2, CYP1B1, F10, FLT3, HMGCR, KDR, MET, MIF, PTPN1, SRC, XDH |
4.67091 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.52717 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, F10, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PTPN1, SRC, XDH |
4.40527 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CSNK2A1, FLT3, HMGCR, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1 |
4.29752 |
[BP] GO:0042493 |
response to drug
|
ABCG2, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, FABP3, HMGCR, KDR, SRC, TOP1 |
4.26321 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, SRC |
4.13088 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, MET, MIF, MMP9, SRC |
4.05363 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, F10, FABP4, FLT3, HMGCR, KDR, MET, MIF, MMP12, MMP2, MMP9, PTPN1, SRC, XDH |
4.03616 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
4.00795 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, HMGCR, HSD17B2, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TYR |
3.97909 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, HMGCR, MET, MIF, PPARA |
3.96414 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.95864 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.91744 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.84669 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.82149 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
3.81722 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, XDH |
3.75988 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.75988 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.72608 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, XDH |
3.68311 |
[BP] GO:0014070 |
response to organic cyclic compound
|
BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FLT3, RORC, SRC, TYR |
3.5595 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.5595 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, F10, IGF1R, KDR, MET, MIF, MMP9, SRC |
3.5541 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, TYR, XDH |
3.5505 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
3.35937 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, HMGCR, KDR, MIF, SRC |
3.33746 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.33746 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TOP1, TYR, XDH |
3.24818 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TOP1, TYR, XDH |
3.22911 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HMGCR, PPARA, RORC, SRC |
3.22702 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.21004 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.19746 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC |
3.19737 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, FLT3, MET, MIF, PIM1, SRC, TYR |
3.16625 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HMGCR, HSD17B1, HSD17B2 |
3.15421 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, PPARA, SRC |
3.14735 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, HMGCR, IGF1R, MET, MIF, MMP9, PTPN1, SRC, XDH |
3.11597 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTPN1, SRC |
3.11597 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
3.09095 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF |
3.08128 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.07929 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MIF, MMP2, MMP9, PTPN1, RORC, SRC |
3.07023 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.07023 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, BCL2, CYP1A1, CYP1B1, HMGCR, KDR, SRC |
3.00758 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, PPARA, RORC, SRC, TOP1 |
2.98913 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.98539 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF |
2.97899 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.95856 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, F10, FLT3, IGF1R, KDR, MET, SRC, TOP1 |
2.95613 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD17B1, HSD17B2, MIF |
2.95165 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, HMGCR, TYR |
2.94458 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.93582 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, RORC, SRC |
2.9326 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.9326 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.9326 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA |
2.91837 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, AURKB, AXL, BCL2, CDC25B, CSNK2A1, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TOP1, XDH |
2.90093 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, FABP4, FLT3, HMGCR, IGF1R, KDR, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
2.88545 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
2.86749 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, FABP3, FLT3, HMGCR, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.84492 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, FABP3, FLT3, HMGCR, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.84492 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, F10, FLT3, HMGCR, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TOP1, TYR, XDH |
2.84431 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
2.84048 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.78155 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, KDR, SRC |
2.75303 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, FLT3, HMGCR, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.71684 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, FABP3, FABP4, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
2.69775 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, AURKB, AXL, BCL2, CDC25B, CSNK2A1, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TOP1, XDH |
2.69127 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, AKR1B1, AXL, BCL2, CA12, CA2, CA7, FABP3, FABP4, FLT3, MET, SRC |
2.68689 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, HMGCR |
2.68689 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
2.68689 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.67901 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD17B1, HSD17B2 |
2.6774 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, F10, FABP4, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, PPARA, PTPN1, SRC, XDH |
2.65811 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.64889 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, FABP4, FLT3, HMGCR, IGF1R, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.64889 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, HMGCR, IGF1R, MIF, PTPN1, SRC |
2.61817 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, FLT3, HMGCR, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.59138 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.5827 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.57814 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.56837 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, HSD17B2, KDR, MMP9, PIM1, PPARA, RORC, SRC, TYR |
2.56837 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, HMGCR, MMP2, PPARA, SRC, TYR |
2.55358 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AXL, BCL2, CYP1A1, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, RORC, SRC |
2.51439 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.48339 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.48339 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, HMGCR, MIF, SRC |
2.46431 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, FLT3, HMGCR, KDR, MIF, PTPN1, SRC, XDH |
2.44083 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.43959 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CYP19A1, FABP4, HMGCR, IGF1R, MET, MIF, MMP12, MMP2, PPARA, PTPN1, SRC, XDH |
2.43822 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.43207 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.40886 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CYP19A1, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPN1, SRC, XDH |
2.37521 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9 |
2.34638 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC |
2.34227 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF |
2.34227 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33971 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, SRC, XDH |
2.33322 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, SRC, XDH |
2.32267 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTPN1, SRC |
2.31334 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, F10, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, XDH |
2.30603 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.30581 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, MIF |
2.30581 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC |
2.29021 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.27248 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, FLT3, HMGCR, IGF1R, KDR, MIF, PTPN1, SRC, XDH |
2.26665 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, MIF |
2.25925 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.20435 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, MIF |
2.19328 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.1856 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, MIF, PTPN1, SRC |
2.16417 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, FABP3, FABP4, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
2.139 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.13627 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SRC |
2.11781 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, PPARA |
2.10365 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, AURKB, BCL2, CDC25B, CSNK2A1, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, XDH |
2.08411 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, MIF |
2.08411 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CA7, CYP19A1, HMGCR, MIF, MMP12, MMP9, PPARA, PTPN1, SRC |
2.08094 |
[BP] GO:0006082 |
organic acid metabolic process
|
ABCG2, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PIM1, PPARA, TYR |
2.05305 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, F10, IGF1R, KDR, MET, MMP9, SRC |
2.04208 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, FABP4, HMGCR, KDR, MET, MIF, MMP12, PPARA |
2.02547 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.02547 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.02547 |
[BP] GO:0030198 |
extracellular matrix organization
|
CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.0122 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, FABP4, FLT3, HMGCR, IGF1R, MIF, PTPN1, SRC |
2.00896 |
[BP] GO:0043062 |
extracellular structure organization
|
CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.00896 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, MIF |
2.00347 |
[BP] GO:0065007 |
biological regulation
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TOP1, XDH |
2.00177 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.02547 |
[CC] GO:0044444 |
cytoplasmic part
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, KDR, MIF, MMP2, MMP9, PIM1, PTPN1, SRC, TOP1, TYR, XDH |
1.78211 |
[CC] GO:0005783 |
None
|
ADORA1, BCL2, CA4, CYP19A1, FLT3, HMGCR, KDR, PTPN1, XDH |
1.57253 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FLT3, HMGCR, HSD17B2, PTPN1 |
1.28965 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9 |
1.21396 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.4702 |
[MF] GO:0003824 |
catalytic activity
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FLT3, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TOP1, TYR, XDH |
10.4702 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
10.3359 |
[MF] GO:0043167 |
ion binding
|
ABCG2, ACHE, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TOP1, TYR, XDH |
8.07586 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.86464 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.217 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
4.68528 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, HSD17B2, TYR, XDH |
4.29752 |
[MF] GO:0008144 |
drug binding
|
ABCG2, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP1 |
4.01943 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.96414 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.96414 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.84051 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.81055 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HMGCR, HSD17B1, HSD17B2, XDH |
3.5595 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.40533 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
3.34062 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.21607 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
3.18462 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
3.16678 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
3.11597 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.03429 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
3.02598 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
3.00758 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD17B1, HSD17B2 |
2.76577 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
2.66004 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.65449 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.634 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, F10, FLT3, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TOP1 |
2.60333 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD17B1, SRC, XDH |
2.5827 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.53832 |
[MF] GO:0036094 |
small molecule binding
|
ABCG2, ADORA1, AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP1, XDH |
2.46565 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP1 |
2.40886 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.34227 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.2832 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, HMGCR, MET, PPARA, PTPN1 |
2.25925 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, MMP1, MMP12, MMP2, MMP9 |
2.1726 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.17091 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, BCL2, CSNK2A1, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP9, TYR, XDH |
2.05135 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.02547 |